Moomoo AI 已提取核心信息
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 14,903 shares of common stock on March 4, 2024. The transaction was executed at a price of $11.1212 per share, resulting in a total sale value of approximately $165,739.24. Following the sale, Watanabe directly holds 874,533 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through trusts and an LLC. The sale was conducted in the open market.
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 14,903 shares of common stock on March 4, 2024. The transaction was executed at a price of $11.1212 per share, resulting in a total sale value of approximately $165,739.24. Following the sale, Watanabe directly holds 874,533 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through trusts and an LLC. The sale was conducted in the open market.
与Arcutis Biotherapeutics有联系的渡边托德·富兰克林于2024年3月4日完成了14,903股普通股的出售。该交易以每股11.1212美元的价格执行，总销售价值约为165,739.24美元。出售后，渡边直接持有该公司874,533股股份。此外，渡边通过信托和有限责任公司间接拥有231,140股股份。此次出售是在公开市场上进行的。
与Arcutis Biotherapeutics有联系的渡边托德·富兰克林于2024年3月4日完成了14,903股普通股的出售。该交易以每股11.1212美元的价格执行，总销售价值约为165,739.24美元。出售后，渡边直接持有该公司874,533股股份。此外，渡边通过信托和有限责任公司间接拥有231,140股股份。此次出售是在公开市场上进行的。
有用
没用